New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;FB;PMFG From The Last 14 Days
Check below for free stories on BMY;FB;PMFG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
May 19, 2013
17:10 EDTFBFacebook's Waze deal being held up by move from Israel, NY Post says
Facebook’s negotiations to buy mapping firm Waze are being held up as founders of Waze, based in Israel, are holding out for more money, the NY Post says. Citing sources, the Post says that Waze founders want more money if they are going to be forced to move from Israel to Silicon Valley as part of the deal. Reference Link
May 17, 2013
13:21 EDTBMYOptions with increasing implied volatility: CPRT BMY GDI HNZ
Subscribe for More Information
06:51 EDTFBFacebook volatility at low end of historic range
Subscribe for More Information
06:36 EDTFBGoogle to add new apps to Google Glass, NY Times says
Subscribe for More Information
May 16, 2013
16:32 EDTBMYBristol-Myers announces intention to voluntarily delist preferred stock
Subscribe for More Information
13:20 EDTBMYFollow-up: Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Bristol-Myers citing the company's multi-billion dollar immuno-oncology prospects. The firm says there were additional responses reported in the press briefing with combination nivolumab and Yervoy. Leerink has a $51 price target for shares.
13:14 EDTBMYBristol-Myers upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information
08:55 EDTBMYBofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information
08:38 EDTBMYBristol-Myers shares likely to give back recent gains, says Leerink
Leerink expects shares of Bristol-Myers to give back recent gains after ASCO published abstracts last night. The firm found the abstracts as in-line with, but not above, its expectations for nivolumab alone or immuno-oncology combination therapy and keeps a Market Perform rating on Bristol-Myers.
05:59 EDTFBHigh tech firms involved in immigration battle, WSJ reports
Subscribe for More Information
05:57 EDTFBFacebook implied volatility at lower end of index mean range
Subscribe for More Information
05:52 EDTBMYStocks with implied volatility movement; BMY SLV
Subscribe for More Information
May 15, 2013
17:46 EDTFBSAC Capital gives quarterly update on stakes
NEW STAKES: Discovery (DISCA), Liberty Global (LBTYA), Liberty Media (LMCA), Norwegian Cruise Line (NCLH), and Cubist (CBST). INCREASED STAKES: Suncor (SU), EQT Corporation (EQT), Amazon.com (AMZN), Visa (V), and GNC Holdings (GNC). DECREASED STAKES: News Corp. (NWSA), Facebook (FB), Sherwin-Williams (SHW), and Avago (AVGO). LIQUIDATED STAKES: Coach (COH), Dover (DOV), and Virgin Media (VMED), .
11:28 EDTBMYOptions with increasing implied volatility: BMY AGNC EBIX IAU
Subscribe for More Information
09:43 EDTBMYActive equity option families trading on open
Subscribe for More Information
05:59 EDTFBCorporate boards recruit newcomers with digital knowledge, WSJ reports
Subscribe for More Information
May 14, 2013
17:48 EDTFBLone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES).
07:24 EDTBMYEBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16.
06:07 EDTFBAT&T may drop HTC Facebook phone, Bloomberg reports
Subscribe for More Information
05:53 EDTFBWeb browsers are being reinvented, WSJ reports
Subscribe for More Information
May 13, 2013
12:17 EDTFBFacebook's Waze deal hits snag, BGR reports
Facebook's acquisition of social navigation company Waze has hit some complications, said BGR, citing a report from the Israeli newspaper Calcalist. The main area of contention is Facebook's desire to close Waze’s Israel-based R&D center and transfer several employees to the U.S., the report said. Reference Link
06:40 EDTFB Facebook Home not very popular so far, AllThingsD says
Less than 1M people have downloaded Facebook's (FB) new Android app, Facebook Home, since the app was released about a month ago, AllThingsD reported Friday afternoon, citing statements by the social network. As far as popularity is concerned, the app is "not exactly a home run," AllThingsD stated. On the other hand, it is only currently available for five devices that use Google's (GOOG) Android operating system, the website added. Reference Link
May 12, 2013
13:44 EDTFBFacebook's general counsel leaving company, AllThingsD says
Facebook’s general counsel Ted Ullyot is leaving the company to take some time off. Ullyot will be leaving in July and the search for his replacement will include internal and external candidates, says AllThingsD. Reference Link
May 10, 2013
11:48 EDTBMYDrugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information
10:53 EDTFBFacebook adds Facebook Home launcher to more Android phones, androidcentral says
Facebook (FB) has added the Facebook Home launcher to a number of smartphones using Google's (GOOG) Android operating system, including Samsung's (SSNLF) Galaxy S4 and the HTC One, androidcentral reported last night. Reference Link
May 9, 2013
12:12 EDTFBLeon Cooperman names Facebook, Qualcomm as stock picks
Subscribe for More Information
10:17 EDTBMYShire trades higher in London amid takeover chatter, Guardian says
Subscribe for More Information
06:17 EDTFBFacebook smartphone discounted to 99c at AT&T, NY Post reports
Subscribe for More Information
05:22 EDTFBFacebook in talks to acquire Waze for about $1B, Reuters reports
Subscribe for More Information
May 8, 2013
10:33 EDTBMYBristol-Myers, Pfizer announced results from ARISTOTLE trial subanalysis
Bristol-Myers (BMY) and Pfizer (PFE) announced yesterday that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from the subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. This story corrects a headline from yesterday.
07:11 EDTFBTarget uses Facebook to see if deals attract shoppers to stores, Reuters reports
Target (TGT) is rolling out a service that combines social networking and discounts to attract shoppers into its physical stores. The company’s program relies on shoppers using their Facebook (FB) accounts, and they can only redeem the offers they choose in Target's U.S. stores, not online, reports Reuters.Reference Link
06:05 EDTFBOn the Fly: Periodicals Wrap-Up
Subscribe for More Information
May 7, 2013
18:34 EDTFBFacebook settles litigation with Timelines, Bloomberg says
Subscribe for More Information
10:54 EDTFBMedia buyers upping budgets for FBX, site, search retargeting, eMarketer says
More media buyers are planning to increase their investments in site, search and Facebook Exchange re-targeting, according to eMarketer, citing a survey by media-buying platform Chango. Reference Link
May 6, 2013
19:05 EDTFBSenate passes bill allowing states to tax Internet purchases, AP reports
Subscribe for More Information
17:03 EDTBMYBristol-Myers, Pfizer announce publication of ARISTOTLE trial
Bristol-Myers Squibb (BMY) and Pfizer (PFE) announced that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from this subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. Based on the results of the subanalysis, the benefits of Eliquis compared with warfarin for stroke or systemic embolism, bleeding, and mortality appear similar across the range of centers' and patients' quality of INR control.
14:06 EDTFBFacebook to launch video advertising in newsfeed, FT reports
Subscribe for More Information
13:37 EDTFBYahoo a possible takeover target for Facebook, analyst says
Subscribe for More Information
13:09 EDTFBYahoo initiated with a Buy at Tigress Financial
Subscribe for More Information
10:43 EDTFBFacebook management to meet with Pacific Crest
Subscribe for More Information
10:00 EDTFBFacebook falls back through $28, levels to watch
Subscribe for More Information
08:53 EDTBMYBofA/Merrill's major pharma analysts hold an analyst/industry conference call
Subscribe for More Information
07:27 EDTBMYBristol-Myers, AstraZeneca announces results of metreleptin study
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.